| 000 | 01803ngm a2200457 a 4500 | ||
|---|---|---|---|
| 001 | HST4023 | ||
| 003 | UkLoHST | ||
| 006 | m c | ||
| 007 | cr|cna|||a|||| | ||
| 007 | vz|czazum | ||
| 008 | 150708s2015 enk|||||||||||s|||v|eng d | ||
| 028 | 5 | 0 |
_a4023 _bHenry Stewart Talks |
| 035 | _a(UkLoHST)3062 | ||
| 040 |
_aUkLoHST _beng _cUkLoHST |
||
| 100 | 1 |
_aO'Hagan, Derek T. _4spk |
|
| 245 | 1 | 0 |
_aVaccine adjuvants _h[electronic resource] : _bpart 2 of 2 / _cDerek O'Hagan. |
| 246 | 3 | _aVaccine adjuvants, part 2 of 2 | |
| 260 |
_aLondon : _bHenry Stewart Talks, _c2015. |
||
| 300 |
_a1 online resource (1 streaming video file (35 min.) : _bcolor, sound). |
||
| 490 | 1 |
_aVaccines : principles, recent developments and future directions, _x2056-452X |
|
| 500 | _aAnimated audio-visual presentation with synchronized narration. | ||
| 500 | _aTitle from title frames. | ||
| 505 | 0 | _aContents: Second generation adjuvants -- Toll-like receptor (TLR) agonists -- Small molecule immune potentiators (SMIPs) -- Adjuvant safety -- Future adjuvants. | |
| 506 | _aAccess restricted to subscribers. | ||
| 538 | _aMode of access: World Wide Web. | ||
| 650 | 0 | _aImmunological adjuvants. | |
| 650 | 0 |
_aVaccines _xDevelopment. |
|
| 650 | 0 |
_aVaccines _xResearch. |
|
| 650 | 2 | _aAdjuvants, Immunologic. | |
| 650 | 2 | _aAdjuvants, Pharmaceutic. | |
| 650 | 2 | _aDrug Delivery Systems. | |
| 650 | 2 | _aImmunosuppressive Agents. | |
| 650 | 2 | _aTechnology, Pharmaceutical. | |
| 650 | 2 | _aToll-Like Receptor 2. | |
| 650 | 2 |
_aVaccination _xmethods. |
|
| 650 | 2 |
_aVaccines _xchemistry. |
|
| 650 | 2 |
_aVaccines _ximmunology. |
|
| 830 | 0 |
_aHenry Stewart talks. _pBiomedical & life sciences collection. _pVaccines. |
|
| 856 | 4 | 0 | _uhttps://hstalks.com/bs/3062/ |
| 856 | 4 | 2 |
_uhttps://hstalks.com/bs/p/923/ _3Series |
| 999 |
_c76875 _d76875 |
||